Abstract
In the last three decades, an increasing number of pathogens resistant to common antibiotics have been a serious threat to public health worldwide. Pleuromutilin, its derivatives and others natural products are important in the fight against pathogen resistant to common antibiotics, such as in respiratory diseases. The aim of the current review is to highlight the most important pleuromutilin derivatives described in the literature between the years of 2007 and 2009.
Keywords: Natural products, drugs, pleuromutilin, respiratory diseases
Current Respiratory Medicine Reviews
Title: Recent Developments in Pleuromutilin Derivatives: A Promising Class Against Bacterial Respiratory Disease
Volume: 6 Issue: 2
Author(s): Raoni Schroeder Borges Goncalves and Marcus Vinicius Nora de Souza
Affiliation:
Keywords: Natural products, drugs, pleuromutilin, respiratory diseases
Abstract: In the last three decades, an increasing number of pathogens resistant to common antibiotics have been a serious threat to public health worldwide. Pleuromutilin, its derivatives and others natural products are important in the fight against pathogen resistant to common antibiotics, such as in respiratory diseases. The aim of the current review is to highlight the most important pleuromutilin derivatives described in the literature between the years of 2007 and 2009.
Export Options
About this article
Cite this article as:
Schroeder Borges Goncalves Raoni and Vinicius Nora de Souza Marcus, Recent Developments in Pleuromutilin Derivatives: A Promising Class Against Bacterial Respiratory Disease, Current Respiratory Medicine Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339810791171287
DOI https://dx.doi.org/10.2174/157339810791171287 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
P-Chiral Oligonucleotides in Biological Recognition Processes
Current Topics in Medicinal Chemistry Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising
Current Drug Metabolism P53 Gene Therapy Sensitizes Resistant Breast Cancer Cells to Doxorubicin Chemotherapy
Drug Delivery Letters Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design Aging and immunopathology in primary Sjögren's syndrome
Current Aging Science Imatinib Mesylate (Gleevec©): Targeted Therapy Against Cancer with Immune Properties
Endocrine, Metabolic & Immune Disorders - Drug Targets Clinical and Imaging Features of Tumors in the Scapula
Current Medical Imaging Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in Cancer
Current Vascular Pharmacology Pharmacophore and 3D QSAR Study of TGFβ Inhibitors
Letters in Drug Design & Discovery Recent Developments in Nanoparticle Based Targeted Delivery of Chemotherapeutics
Current Bioactive Compounds CD4+ T Cell Responses in the Immune Control Against Latent Infection by Epstein-Barr Virus
Current Molecular Medicine New Vascular Disrupting Agents in Upper Gastrointestinal Malignancies
Current Medicinal Chemistry Therapeutic Proteins in Tumors and Targeted Therapeutic Agents for Cancer Patients
Protein & Peptide Letters Role of Cathepsin K in Normal Joints and in the Development of Arthritis
Current Drug Targets ChemoImmunoModulation: Immune Regulation by the Antineoplastic Chemotherapeutic Agents
Current Medicinal Chemistry Mutagenic Approaches to Modifying Gap Junction Phenotype
Current Drug Targets Lymphatic Delivery of Anti-HIV Drug Nanoparticles
Recent Patents on Nanotechnology Xeno-Cannibalism as an Exacerbation of Self-Cannibalism: A Possible Fruitful Survival Strategy for Cancer Cells
Current Pharmaceutical Design Non-Infectious Complications of Immunosuppressant Medications in Renal Transplant Patients
Current Clinical Pharmacology CD133+ Glioblastoma Stem-Like Cells Induce Vascular Mimicry in Vivo
Current Neurovascular Research